对T细胞淋巴瘤的生物学有新的见解
Javeed Iqbal1, Giorgio Inghirami2, Wing C Chan3
1Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE.
Blood
|August 30, 2024
概括
周围T细胞淋巴瘤 (PTCL) 是具有低生存率的侵袭性癌症. 基因组分析的进步正在揭示新的生物标志物和分子特征,以改善PTCL诊断和指导向治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 代表了一组多样化的侵略性T细胞恶性瘤,治疗选择有限,预后不佳.
- 目前的诊断挑战源于显著的瘤内部和瘤内部异质性,阻碍了有效的治疗策略.
研究的目的:
- 审查了解PTCL病理生物学方面的最新进展,重点关注分子发现.
- 突出转录组分析和基因组测序在识别新生物标记物和完善PTCL分类中的作用.
主要方法:
- 关于PTCL病变发生,诊断和分子分析的当前文献的综述.
- 对全基因组调查的分析,包括突变景观和转录基因资料.
- 讨论与PTCL相关的正常T细胞发育和信号通路.
主要成果:
- 基因组和转录组研究已经确定了PTCL亚型中的关键分子变化和特征.
- 原始细胞越来越被认为是PTCL生物学的一个关键决定因素.
- 发现正在为修订的分类和精确疗法的发展提供信息.
结论:
- 通过分子研究,人们对PTCL实体有了更深入的生物学理解.
- 基于分子特征的PTCL亚型的分层对未来的研究和临床试验至关重要.
- 需要改进诊断和向治疗,以改善PTCL患者的治疗结果.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.6K
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
306
相关概念视频
T Cell Activation and Clonal Selection
691
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
691
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
